Drug Development

Articles

Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.

Albumin Attachment Can Make Better Biobetters

Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.

GlobalData Reports on Barriers Impeding Biosimilar Entry into US Market

The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.

Lonza, Proteon Therapeutics Extend API Manufacturing Partnership

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation.

The Role of Carriers in DPI Capsules

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.

Consistent API Quality Calls for Collaboration

Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.

Porton Pharma Solutions and Codexis Partner on Biocatalysts

The new platform is expected to speed up cell line development.

Sanofi Buys Berkeley Lights’ Cell Line Platform

The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.

AMRI Wins NIH Contract Renewal for Neurotherapeutics

Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.

J&J, BMS Team Up on Cardiovascular Therapies

The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.

APIs and Excipients